Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles. (2022)

First Author: Espejo-Román JM
Attributed to:  CCP-BioSim: Biomolecular Simulation at the Life Sciences Interface funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics14040788

PubMed Identifier: 35456622

Publication URI: http://europepmc.org/abstract/MED/35456622

Type: Journal Article/Review

Volume: 14

Parent Publication: Pharmaceutics

Issue: 4

ISSN: 1999-4923